SI
LUCD icon

Sprott Inc’s Lucid Diagnostics LUCD Stock Holding History

Sprott Inc’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23K Hold
20,000
– – ﹤0.01% 238
2025
Q4 		$21.8K Sell
20,000
-5,000
-20% -$5.59K ﹤0.01% 214
2025
Q3 		$25.3K Buy
+25,000
New +$27.3K ﹤0.01% 207

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Sprott Inc's LUCD Position: Q1 2026 in Review

Sprott Inc held its Lucid Diagnostics (LUCD) position steady in Q1 2026 at 20,000 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #238.

Sprott Inc first reported a position in LUCD in Q3 2025 and has held it in 3 quarters since. The position peaked at $25.3K in Q3 2025. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Sprott Inc held 20,000 shares of Lucid Diagnostics worth $23K as of Q1 2026.
  • Sprott Inc left its Lucid Diagnostics share count unchanged in Q1 2026.
  • Lucid Diagnostics made up ﹤0.01% of Sprott Inc's portfolio in Q1 2026, its #238 holding.
  • Sprott Inc first reported a position in Lucid Diagnostics in Q3 2025 and has held it in 3 quarters since.
  • Sprott Inc's Lucid Diagnostics position peaked at $25.3K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Sprott Inc's 13F filing for Q1 2026, filed 8 May 2026.